icon-folder.gif   Conference Reports for NATAP  
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
No Resistance Detected in Four Phase 3 Clinical Studies in HCV Genotypes 1-6 of Sofosbuvir + Ribavirin With or Without Peginterferon
  Reported by Jules Levin, NATAP, www.natap.org
AASLD 2013 Nov 1-4 Wash DC
Evguenia S. Svarovskaia,1 Hadas S. Dvory-Sobol,1 Christy Hebner,1 Brian Doehle,1 Viktoria Gontcharova,1 Ross Martin,1 Edward J. Gane,2 Ira M. Jacobson,3 David R. Nelson,4 Eric Lawitz,5 B. Nebiyou Bekele,1 Diana M. Brainard,1 William T. Symonds,1 John G. McHutchison,1 Michael D. Miller,1 Hongmei Mo1 1Gilead Sciences, Inc., Foster City, CA; 2University of Auckland, Auckland City Hospital, New Zealand; 3Weill Cornell Medical College, New York, NY; 4University of Florida, Gainesville; 5Texas Liver Institute, San Antonio, TX